How soon will you feel the effects of semaglutide?

What do people notice first, and when?

The earliest signal most people describe is a shift in how hungry they feel, not hunger disappearing entirely, but the urgency dialling down. Wegovy works by activating GLP-1 receptors in the brain and gut, slowing how quickly the stomach empties and signalling satiety to the hypothalamus. Those mechanisms kick in from the very first injection, which is why some people notice something within 48–72 hours. For others it takes the full first week.

What changes first isn't always weight on the scales. It's appetite architecture: the pull towards large portions, the impulse snacking between meals, the difficulty stopping halfway through a plate. These shifts are what the broader effects of semaglutide section covers in depth, but in brief, the food-quiet feeling is often the headline change in week one.

Nausea can show up in the same window. It's the most commonly reported early side effect, and while it's rarely severe, it can be unsettling if you weren't expecting it. It tends to be worst in the first few days after a dose change, then settles. The full picture of how Wegovy tends to feel day to day is worth reading before you start, so nothing catches you off guard. The NHS medicines page for semaglutide lists the common side effects clearly and is a reliable first reference.

When does weight loss actually start showing up?

This is the question behind the question. People asking how soon they'll feel semaglutide's effects are usually asking: when will I see it working?

Honest answer: the appetite changes come first, the weight follows. Most people lose some weight in the first month, but the numbers on the scale at week four don't reflect the full picture. The STEP 1 trial, published in the New England Journal of Medicine, showed an average of around 15% body-weight reduction over 68 weeks at the 2.4 mg maintenance dose, that's a trajectory, not a sprint. The meaningful losses accumulate in months two, three and beyond, as the dose titrates upward.

The starting dose of 0.25 mg exists to let your body adjust, not to deliver the therapeutic effect. Titration happens roughly every four weeks, guided by your prescriber. By the time you reach 1.7 mg or 2.4 mg, most people are seeing consistent monthly losses. If you want to understand when Wegovy's effects typically build to their peak, the short version is: expect the curve to steepen somewhere between months two and four.

Timing matters practically too. Someone who starts on a Monday in the middle of a particularly stressful fortnight (or right before a holiday) may find the first few weeks harder to read. Life context shapes what you notice and when.

Are some effects felt earlier than others?

Yes, and it's worth separating them. Appetite suppression and reduced cravings are early. Measurable weight loss is mid-term. The longer-range benefits (improvements in blood pressure, cholesterol, blood sugar) take longer still and require monitoring by your clinical team.

Digestive changes sit in their own category. Nausea, loose stools, constipation, or reflux can appear quickly, especially after the first injection or a dose increase. These are typically transient; the systemic effects semaglutide has on the body include both the wanted and the adjustment-phase ones, and it helps to keep them distinct in your own tracking.

One thing that surprises some people: energy and mood can shift noticeably early in treatment. Some people feel brighter as nausea fades; others feel more fatigued during the adjustment window. Neither is unusual. The semaglutide overview covers the mechanism and licensed uses in the UK, which provides useful context for what you're experiencing and why.

If you're considering treatment or want to understand your eligibility, the weight-loss treatments overview gives a clear picture of the options licensed for weight management in the UK. For a more detailed look at the Wegovy-specific timeline, this guide to when semaglutide effects tend to peak goes further into the titration curve.

When should you be concerned rather than patient?

Most early side effects resolve on their own. But some symptoms warrant prompt medical attention, and it's important to know the difference before you start.

Severe, persistent abdominal pain that spreads to the back, with or without vomiting, should not be waited out. The MHRA flagged acute pancreatitis in a January 2026 Drug Safety Update covering GLP-1 medicines: rare but serious, and worth acting on quickly if those symptoms appear. Gallbladder symptoms (sudden right-sided upper abdominal pain, especially after eating) are another reason to seek help rather than hoping it passes. Signs of an allergic reaction (swelling, difficulty breathing, a widespread rash) require urgent attention.

You can report any suspected side effects via the MHRA Yellow Card scheme, which also accepts reports from patients, not just clinicians. It's a straightforward process and genuinely useful for monitoring emerging safety signals.

If you have questions about what you're experiencing on treatment, our aftercare team is available seven days a week. And if you haven't yet started but are weighing up whether Wegovy is right for you, check your eligibility with a free consultation, a GPhC-registered prescriber reviews every application personally.